🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

👉🏼 commentary on DCE positive prostate lesions 👉🏼 read the original paper - very interesting and important! Are upgraded DCE-positive PI-RADS 3 lesions truly suspicious for clinically significant prostate cancer? pubmed.ncbi.nlm.nih.gov/37154954/

Great overview by Anwar Padhani on Prostate Cancer Detection Using Artifical Inteligence Software - 2023 Up... youtu.be/JIPsFIpGCBA via YouTube

Commentary: Contrast-medium administration for #prostate MRI - yes! Contrast-medium administration can be abandoned. (Patrick Asbach, Charité - Universitätsmedizin Berlin) #EuropeanRadiology 🔗 buff.ly/3OgYRDG

Happy to share our new study on transition zone-specific PSAD for prostate biopsy planning. rdcu.be/dCIrL ⬆️specificity + ↔️sensitivity = ⬆️accuracy in GG2 #ProstateCancer detection European Radiology Charité - Universitätsmedizin Berlin Anwar Padhani Patrick Asbach Hannes Cash ESUR Junior Network

In this edition of Coffee break, we do an overview of this faltastic article from @charlie_charite about using zone specific PSA density. According to the authors "Using the sPSAD-based BDS, false positives were reduced by 25%" ... Gocheck it out! rdcu.be/dFbkb

Thrilled to share our new study presenting initial prospective data on AI-guided prostate biopsy management: authors.elsevier.com/c/1i-uV8Yy0LUa… Many thanks to Karsten Guenzel for the fantastic collaboration! #ProstateCancer Eur Urol Focus Charité - Universitätsmedizin Berlin Vivantes Netzwerk für Gesundheit GmbH @berlinnovation ESUR Junior Network

You have something to read ✅ Also, if you are into image based prostate procedures (and you are an ESUR member), you can go see our webinar too! It's available online 😎 esur.org/webinars-2024/

✅ New ESR Essential in European Radiology ➡ Using the right scoring system in #prostate MRI—practice recommendations by #ESUR 🖇 link.springer.com/article/10.100… European Society of Urogenital Radiology ESUR Junior Network myesr

Traditions are important - the JN night out! We are growing, huh? ESUR Junior Network #ESUR2024 #lisbon Francesco Giganti @MaartendeRooij Camilla Panico Jeries Zawaideh Andrea Ponsiglione Jonathan A. Hernández Mancera Charlie Hamm Carlos Carnelli, MD Martina Pecoraro Luca Russo Miriam Dolciami

An engaging session on prostate #MRI. From #prostatecancer diagnosis and staging to recurrence, while emphasizing the importance of #quality! Adriano Dias Ailin Dehghanpour Jonathan A. Hernández Mancera Charlie Hamm Vibeke Løgager Jelle Barentsz @Ema_Messina_ Iztok Caglic ESUR Junior Network #ESUR24

A well organised, well presented session, with challenging cases at #ESUR24 Congratulations especially to the ESUR-Juniors. You did an excellent job! Adriano Dias Ailin Dehghanpour Jonathan A. Hernández Mancera Charlie Hamm Vibeke Løgager @Ema_Messina_ Iztok Caglic ESUR Junior Network European Society of Urogenital Radiology

Proud to share our JAMA Oncology study validating the oncological safety of MRI-guided biopsy decisions in suspected #ProstateCancer. A true honor to work with Patrick Asbach Ivo Schoots Veeru Kasi Hannes Cash on this 3-year monitoring study. Charité - Universitätsmedizin Berlin ja.ma/41vdL02

Last 2024coffee break ☕️? Charlie Hamm and the team say "The main finding of this prospective, multisite trial demonstrated that prebiopsy prostate MRI, as an integral component of the MRI pathway, is feasible in a community-based setting and oncologically safe" go read it🔓

Happy to share our commentary led by Anwar Padhani on the PROKOMB trial, shorturl.at/gCWSz discussing: 1⃣Long-term safety of avoided Bx: MRI(-)👉≥GG2 4% @3yr) 2⃣Risk stratification 3⃣High-quality reporting 4⃣Re-thinking guidelines 5⃣Implications for AI development #pcsm

Most viewed in the last 7 days from JAMA Oncology: Men with negative multiparametric MRI results avoiding biopsy were not at elevated risk of clinically significant prostate cancer. ja.ma/3BF8usc

Oncological Safety of MRI-Informed Biopsy Decision-Making in Men With Suspected Prostate Cancer jamanetwork.com/journals/jamao… Cohort study evaluated the feasibility and safety of using a community-based MRI diagnostic pathway to avoid prostate biopsy (PB) in men with suspected